header advert
Orthopaedic Proceedings Logo

Receive monthly Table of Contents alerts from Orthopaedic Proceedings

Comprehensive article alerts can be set up and managed through your account settings

View my account settings

Visit Orthopaedic Proceedings at:

Loading...

Loading...

Full Access

General Orthopaedics

Successful Infection Control After Single - Stage (Direct-Exchange) Revision Arthroplasty for Acute Infection of Cementless Total Hip Arthroplasty

International Society for Technology in Arthroplasty (ISTA) 2012 Annual Congress



Abstract

Introduction

Acute infection following Total Hip Arthroplasty (THA) is a serious complication. It is commonly treated by irrigation and debridement (I&D) with component retention (exchange only the mobile parts of the joint - head and liner). However, the reported re-infection rate with the use of this approach remains high. We are reporting our experience in using single - stage revision arthroplasty in treating acute infection of THA. We hypothesized that the infection control rate after immediate early revision for acute infection of cementless implants is better than has been reported for I&D with exchange of mobile parts.

Methods

From our infection arthroplasty database, we reviewed the outcome of 19 patients who had an acute infection (within 6 weeks) of cementless THA. Our management strategy includes I&D and single-stage (direct-exchange) revision arthroplasty followed by 6 weeks course of culture specific oral antibiotics.

Results

Patients' average age was 64 year (39–85), M:F = 11:8. There were 13 primary and 6 revision cementless THAs. Average time from the index operation to the development of clinical symptoms of infection was 18 days (4–41). 14 patients (73.7%) were successfully treated with single stage revision strategy with no evidence of re-infection at 64.3 (32–89) months of follow up. 5 patients (26.3%) developed re-infection requiring two stage-revision surgery.

Discussion

Our results showed that single stage revision strategy has a better outcome in treating acute infection after THR than the outcomes reported for I&D with component retention. When faced with acute infection of a cementless implant, early implant exchange prior to ingrowth should be considered.